{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:14:45Z","timestamp":1789002885017,"version":"build-2803163510"},"reference-count":159,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>Bilirubin is the main waste product of heme catabolism. At high concentrations, bilirubin may cause toxicity, especially in the brain, kidney, and erythrocytes. Membrane and mitochondrial dysfunction, oxidative stress, apoptosis, necrosis, endoplasmic reticulum stress, excitotoxicity, inflammation, and epigenetic modifications are the main mechanisms of toxicity triggered by bilirubin in susceptible organs. Many studies have shown that there is an interaction between bilirubin and epigenetic modifications in metabolic and immune diseases. In this review, we first outline the toxicity mediated by bilirubin and then summarize the current knowledge linking bilirubin and epigenetic modifications in metabolic and immunometabolic disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871530321666211125102924","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T23:38:30Z","timestamp":1637883510000},"page":"1178-1190","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bilirubin and Epigenetic Modifications in Metabolic and Immunometabolic\nDisorders"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-6858","authenticated-orcid":true,"given":"Mostafa Moradi","family":"Sarabi","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Allied Medicine, Lorestan University of Medical Sciences,\nKhorramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeel","family":"Babaeenezhad","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, School of Medicine, Student Research Committee, Shahid Beheshti\nUniversity of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Allied Medicine, Student\nResearch Committee, Lorestan University of Medical Sciences, Khorramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Kaviani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine School\nof Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhraddin","family":"Naghibalhossaini","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine,\nShiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fphar.2012.00089","volume":"3","author":"Gazzin S.","year":"2012","unstructured":"Gazzin S.; Strazielle N.; Tiribelli C.; Ghersi-Egea J.F.; Transport and metabolism at blood-brain interfaces and in neural cells: Relevance to bilirubin-induced encephalopathy. Front Pharmacol 2012,3,89","journal-title":"Front Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.2174\/138161209789058228","volume":"15","author":"Wennberg R.P.","year":"2009","unstructured":"Wennberg R.P.; Ahlfors C.E.; Aravkin A.Y.; Intervention guidelines for neonatal hyperbilirubinemia: An evidence based quagmire. Curr Pharm Des 2009,15(25),2939-2945","journal-title":"Curr Pharm Des"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"Stocker R.","year":"1987","unstructured":"Stocker R.; Yamamoto Y.; McDonagh A.F.; Glazer A.N.; Ames B.N.; Bilirubin is an antioxidant of possible physiological importance. Science 1987,235(4792),1043-1046","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMra1308124","volume":"369","author":"Watchko J.F.","year":"2013","unstructured":"Watchko J.F.; Tiribelli C.; Bilirubin-induced neurologic damage--mechanisms and management approaches. N Engl J Med 2013,369(21),2021-2030","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1385\/NMM:8:4:513","volume":"8","author":"Watchko J.F.","year":"2006","unstructured":"Watchko J.F.; Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med 2006,8(4),513-529","journal-title":"Neuromolecular Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0022-2275(20)30462-4","volume":"43","author":"Rodrigues C.M.P.","year":"2002","unstructured":"Rodrigues C.M.P.; Sol\u00e1 S.; Castro R.E.; Laires P.A.; Brites D.; Moura J.J.; Perturbation of membrane dynamics in nerve cells as an early event during bilirubin-induced apoptosis. J Lipid Res 2002,43(6),885-894","journal-title":"J Lipid Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1750-3639.2005.tb00526.x","volume":"15","author":"Johnston M.V.","year":"2005","unstructured":"Johnston M.V.; Excitotoxicity in perinatal brain injury. Brain Pathol 2005,15(3),234-240","journal-title":"Brain Pathol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-017-0838-1","volume":"14","author":"Vodret S.","year":"2017","unstructured":"Vodret S.; Bortolussi G.; Ja\u0161prov\u00e1 J.; Vitek L.; Muro A.F.; Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1 -\/- mouse model. J Neuroinflammation 2017,14(1),64","journal-title":"J Neuroinflammation"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/cbf.3126","volume":"33","author":"Sarabi M.M.","year":"2015","unstructured":"Sarabi M.M.; Naghibalhossaini F.; Association of DNA methyltransferases expression with global and gene-specific DNA methylation in colorectal cancer cells. Cell Biochem Funct 2015,33(7),427-433","journal-title":"Cell Biochem Funct"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13148-019-0675-4","volume":"11","author":"Roberti A.","year":"2019","unstructured":"Roberti A.; Valdes A.F.; Torrecillas R.; Fraga M.F.; Fernandez A.F.; Epigenetics in cancer therapy and nanomedicine. Clin Epigenetics 2019,11(1),81","journal-title":"Clin Epigenetics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","volume":"66","author":"Konsoula Z.","year":"2012","unstructured":"Konsoula Z.; Barile F.A.; Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J Pharmacol Toxicol Methods 2012,66(3),215-220","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.3892\/mmr.2016.5606","volume":"14","author":"Sakamoto T.","year":"2016","unstructured":"Sakamoto T.; Morishita A.; Nomura T.; Tani J.; Miyoshi H.; Yoneyama H.; Iwama H.; Himoto T.; Masaki T.; Identification of microRNA profiles associated with refractory primary biliary cirrhosis. Mol Med Rep 2016,14(4),3350-3356","journal-title":"Mol Med Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"143911","DOI":"10.1016\/j.gene.2019.06.001","volume":"712","author":"Liu X.","year":"2019","unstructured":"Liu X.; Ni S.; Li C.; Xu N.; Chen W.; Wu M.; van Wijnen A.J.; Wang Y.; Circulating microRNA-23b as a new biomarker for rheumatoid arthritis. Gene 2019,712,143911","journal-title":"Gene"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/npp.2012.154","volume":"38","author":"Rogge G.A.","year":"2013","unstructured":"Rogge G.A.; Wood M.A.; The role of histone acetylation in cocaine-induced neural plasticity and behavior. Neuropsychopharmacology 2013,38(1),94-110","journal-title":"Neuropsychopharmacology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15376516.2017.1357775","volume":"28","author":"Gou P.","year":"2018","unstructured":"Gou P.; Qi X.; Yuan R.; Li H.; Gao X.; Wang J.; Zhang B.; Tet1-mediated DNA demethylation involves in neuron damage induced by bilirubin in vitro. Toxicol Mech Methods 2018,28(1),55-61","journal-title":"Toxicol Mech Methods"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jvh.12277","volume":"22","author":"Gao S.","year":"2015","unstructured":"Gao S.; Ji X.F.; Li F.; Sun F.K.; Zhao J.; Fan Y.C.; Wang K.; Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 predicts prognosis of acute-on-chronic hepatitis B liver failure. J Viral Hepat 2015,22(2),112-119","journal-title":"J Viral Hepat"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.26047","volume":"57","author":"Medici V.","year":"2013","unstructured":"Medici V.; Shibata N.M.; Kharbanda K.K.; LaSalle J.M.; Woods R.; Liu S.; Engelberg J.A.; Devaraj S.; T\u00f6r\u00f6k N.J.; Jiang J.X.; Havel P.J.; L\u00f6nnerdal B.; Kim K.; Halsted C.H.; Wilson\u2019s disease: Changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatology 2013,57(2),555-565","journal-title":"Hepatology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jphp.12053","volume":"65","author":"Yasar U.","year":"2013","unstructured":"Yasar U.; Greenblatt D.J.; Guillemette C.; Court M.H.; Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers. J Pharm Pharmacol 2013,65(6),874-883","journal-title":"J Pharm Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2015.08.027","volume":"606","author":"Ji H.","year":"2015","unstructured":"Ji H.; Wang Y.; Liu G.; Xu X.; Dai D.; Chen Z.; Zhou D.; Zhou X.; Han L.; Li Y.; Zhuo R.; Hong Q.; Jiang L.; Zhang X.; Liu Y.; Xu L.; Chang L.; Li J.; An P.; Duan S.; Wang Q.; OPRK1 promoter hypermethylation increases the risk of Alzheimer\u2019s disease. Neurosci Lett 2015,606,24-29","journal-title":"Neurosci Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.14-261537","volume":"29","author":"Bae W.K.","year":"2015","unstructured":"Bae W.K.; Kang K.; Yu J.H.; Yoo K.H.; Factor V.M.; Kaji K.; Matter M.; Thorgeirsson S.; Hennighausen L.; The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration. FASEB J 2015,29(5),1653-1662","journal-title":"FASEB J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.hbpd.2018.09.013","volume":"17","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Zhao L.; Jiao F.Z.; Zhang W.B.; Chen Q.; Gong Z.J.; Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-\u03b21 signal pathway. Hepatobiliary Pancreat Dis Int 2018,17(5),423-429","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3892\/mmr.2017.6290","volume":"15","author":"Zhang H.","year":"2017","unstructured":"Zhang H.; Li X.; Zhang Q.; Yang F.; Chu X.; Zhang D.; Wang L.; Gong Z.; Role of histone deacetylase expression levels and activity in the inflammatory responses of patients with chronic hepatitis B. Mol Med Rep 2017,15(5),2744-2752","journal-title":"Mol Med Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1124\/dmd.117.076109","volume":"45","author":"Nie Y.L.","year":"2017","unstructured":"Nie Y.L.; Meng X.G.; Liu J.Y.; Yan L.; Wang P.; Bi H.Z.; Kan Q.C.; Zhang L.R.; Histone modifications regulate the developmental expression of human hepatic UDP-glucuronosyltransferase 1A1. Drug Metab Dispos 2017,45(12),1372-1378","journal-title":"Drug Metab Dispos"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0006-291X(74)80262-7","volume":"58","author":"Gurba P.E.","year":"1974","unstructured":"Gurba P.E.; Zand R.; Bilirubin binding to myelin basic protein, histones and its inhibition in vitro of cerebellar protein synthesis. Biochem Biophys Res Commun 1974,58(4),1142-1147","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1038\/s41598-018-32106-w","volume":"8","author":"Vianello E.","year":"2018","unstructured":"Vianello E.; Zampieri S.; Marcuzzo T.; Tordini F.; Bottin C.; Dardis A.; Zanconati F.; Tiribelli C.; Gazzin S.; Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat. Sci Rep 2018,8(1),13690","journal-title":"Sci Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"004","DOI":"10.17352\/ahr.000008","volume":"3","author":"Amin M.A.","year":"2017","unstructured":"Amin M.A.; Fawzi M.; Sabri D.; Sedrak H.; Mausa S.; Liver specific serum Micro RNA122 as a prognostic marker in egyptian patients with liver cirrhosis. Arch Hepatitis Res 2017,3(1),004-009","journal-title":"Arch Hepatitis Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/hum.2017.035","volume":"29","author":"Brandon-Warner E.","year":"2018","unstructured":"Brandon-Warner E.; Benbow J.H.; Swet J.H.; Feilen N.A.; Culberson C.R.; McKillop I.H.; deLemos A.S.; Russo M.W.; Schrum L.W.; Adeno-associated virus serotype 2 vector-mediated reintroduction of microRNA-19b attenuates hepatic fibrosis. Hum Gene Ther 2018,29(6),674-686","journal-title":"Hum Gene Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-1550-0","volume":"11","author":"Shao M.","year":"2020","unstructured":"Shao M.; Xu Q.; Wu Z.; Chen Y.; Shu Y.; Cao X.; Chen M.; Zhang B.; Zhou Y.; Yao R.; Shi Y.; Bu H.; Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res Ther 2020,11(1),37","journal-title":"Stem Cell Res Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1535370217741500","volume":"243","author":"Huang Y.H.","year":"2018","unstructured":"Huang Y.H.; Yang Y.L.; Huang F.C.; Tiao M.M.; Lin Y.C.; Tsai M.H.; Wang F.S.; MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice. Exp Biol Med (Maywood) 2018,243(1),13-21","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/glia.22823","volume":"63","author":"Lin S.H.","year":"2015","unstructured":"Lin S.H.; Song W.; Cressatti M.; Zukor H.; Wang E.; Schipper H.M.; Heme oxygenase-1 modulates microRNA expression in cultured astroglia: Implications for chronic brain disorders. Glia 2015,63(7),1270-1284","journal-title":"Glia"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fphar.2020.01012","volume":"11","author":"Vaz A.R.","year":"2020","unstructured":"Vaz A.R.; Falc\u00e3o A.S.; Scarpa E.; Semproni C.; Brites D.; Microglia susceptibility to free bilirubin is age-dependent. Front Pharmacol 2020,11,1012","journal-title":"Front Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1124\/dmd.113.052126","volume":"41","author":"Rieger J.K.","year":"2013","unstructured":"Rieger J.K.; Klein K.; Winter S.; Zanger U.M.; Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: Influence of nongenetic factors and association with gene expression. Drug Metab Dispos 2013,41(10),1752-1762","journal-title":"Drug Metab Dispos"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM200102223440807","volume":"344","author":"Dennery P.A.","year":"2001","unstructured":"Dennery P.A.; Seidman D.S.; Stevenson D.K.; Neonatal hyperbilirubinemia. N Engl J Med 2001,344(8),581-590","journal-title":"N Engl J Med"},{"key":"ref=34","first-page":"765","author":"Hansen T.W.R.","year":"2002","unstructured":"Hansen T.W.R.;  Mechanisms of bilirubin toxicity: Clinical implications 2002,765-778","journal-title":"Mechanisms of bilirubin toxicity: Clinical implications"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.jp.7211157","volume":"25","author":"Shapiro S.M.","year":"2005","unstructured":"Shapiro S.M.; Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005,25(1),54-59","journal-title":"J Perinatol"},{"key":"ref=36","first-page":"82","volume":"2","author":"Song J.","year":"2009","unstructured":"Song J.; Chang A.; Jaundice-associated acute kidney injury. NDT Plus 2009,2(1),82-83","journal-title":"NDT Plus"},{"key":"ref=37","first-page":"1356","author":"Krones E.","year":"2018","unstructured":"Krones E.; Pollheimer M.J.; Rosenkranz A.R.; Fickert P.; Cholemic nephropathy \u2013 Historical notes and novel perspectives. 2018,1356-1366"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/hep.27338","volume":"61","author":"Lang E.","year":"2015","unstructured":"Lang E.; Gatidis S.; Freise N.F.; Bock H.; Kubitz R.; Lauermann C.; Orth H.M.; Klindt C.; Schuier M.; Keitel V.; Reich M.; Liu G.; Schmidt S.; Xu H.C.; Qadri S.M.; Herebian D.; Pandyra A.A.; Mayatepek E.; Gulbins E.; Lang F.; H\u00e4ussinger D.; Lang K.S.; F\u00f6ller M.; Lang P.A.; Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2015,61(1),275-284","journal-title":"Hepatology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0378-3782(79)90047-1","volume":"3","author":"Wennberg R.P.","year":"1979","unstructured":"Wennberg R.P.; Ahlfors C.E.; Rasmussen L.F.; The pathochemistry of kernicterus. Early Hum Dev 1979,3(4),353-372","journal-title":"Early Hum Dev"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.17650\/2073-8803-2019-14-3-7-10","volume":"14","author":"Karimzadeh P.","year":"2020","unstructured":"Karimzadeh P.; Fallahi M.; Kazemian M.; Taslimi Taleghani N.; Nouripour S.; Radfar M.; Bilirubin induced encephalopathy. Iran J Child Neurol 2020,14(1),7-19","journal-title":"Iran J Child Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e000105","DOI":"10.1136\/bmjpo-2017-000105","volume":"1","author":"Slusher T.M.","year":"2017","unstructured":"Slusher T.M.; Zamora T.G.; Appiah D.; Stanke J.U.; Strand M.A.; Lee B.W.; Richardson S.B.; Keating E.M.; Siddappa A.M.; Olusanya B.O.; Burden of severe neonatal jaundice: A systematic review and meta-analysis. BMJ Paediatr Open 2017,1(1),e000105","journal-title":"BMJ Paediatr Open"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.earlhumdev.2009.09.003","volume":"85","author":"Maisels M.J.","year":"2009","unstructured":"Maisels M.J.; Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten. Early Hum Dev 2009,85(11),727-732","journal-title":"Early Hum Dev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/S0021-9258(17)30230-2","volume":"254","author":"Brodersen R.","year":"1979","unstructured":"Brodersen R.; Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem 1979,254(7),2364-2369","journal-title":"J Biol Chem"},{"key":"ref=44","first-page":"94","volume":"72","author":"Ives N.","year":"1985","unstructured":"Ives N.; Brewster F.; Gardiner R.; Bilirubin transport at the blood-brain-barrier investigated using the oldendorf technique. Acta Neurol Scand 1985,72,94","journal-title":"Acta Neurol Scand"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1203\/00006450-198905000-00005","volume":"25","author":"Lee C.","year":"1989","unstructured":"Lee C.; Oh W.; Stonestreet B.S.; Cashore W.J.; Permeability of the blood brain barrier for 125I-albumin-bound bilirubin in newborn piglets. Pediatr Res 1989,25(5),452-456","journal-title":"Pediatr Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1203\/00006450-199601000-00009","volume":"39","author":"Roger C.","year":"1996","unstructured":"Roger C.; Koziel V.; Vert P.; Nehlig A.; Autoradiographic mapping of local cerebral permeability to bilirubin in immature rats: Effects of hyperbilirubinemia. Pediatr Res 1996,39(1),64-71","journal-title":"Pediatr Res"},{"key":"ref=47","first-page":"206A","volume":"27","author":"Gulati A.","year":"1990","unstructured":"Gulati A.; Mahesh A.K.; Misra P.K.; Blood brain barrier permeability studies in control and icteric neonates. Pediatric Research 1990,27,206A","journal-title":"Pediatric Research"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/exnr.1993.1092","volume":"121","author":"Amit Y.","year":"1993","unstructured":"Amit Y.; Brenner T.; Age-dependent sensitivity of cultured rat glial cells to bilirubin toxicity. Exp Neurol 1993,121(2),248-255","journal-title":"Exp Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000244229","volume":"68","author":"Hansen T.W.R.","year":"1995","unstructured":"Hansen T.W.R.; Cashore W.J.; Rates of bilirubin clearance from rat brain regions. Biol Neonate 1995,68(2),135-140","journal-title":"Biol Neonate"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1203\/00006450-198608000-00018","volume":"20","author":"Wennberg R.P.","year":"1986","unstructured":"Wennberg R.P.; Hance A.J.; Experimental bilirubin encephalopathy: Importance of total bilirubin, protein binding, and blood-brain barrier. Pediatr Res 1986,20(8),789-792","journal-title":"Pediatr Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1203\/00006450-199811000-00020","volume":"44","author":"Watchko J.F.","year":"1998","unstructured":"Watchko J.F.; Daood M.J.; Hansen T.W.R.; Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 1998,44(5),763-766","journal-title":"Pediatr Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.addr.2004.07.006","volume":"56","author":"Strazielle N.","year":"2004","unstructured":"Strazielle N.; Khuth S.T.; Ghersi-Egea J.F.; Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. Adv Drug Deliv Rev 2004,56(12),1717-1740","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=53","first-page":"722","volume":"43","author":"Kapitulnik J.","year":"1993","unstructured":"Kapitulnik J.; Gonzalez F.J.; Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 1993,43(5),722-725","journal-title":"Mol Pharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj2420297","volume":"242","author":"Kapitulnik J.","year":"1987","unstructured":"Kapitulnik J.; Hardwick J.P.; Ostrow J.D.; Webster C.C.; Park S.S.; Gelboin H.V.; Increase in a specific cytochrome P-450 isoenzyme in the liver of congenitally jaundiced Gunn rats. Biochem J 1987,242(1),297-300","journal-title":"Biochem J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.bcp.2005.08.009","volume":"70","author":"Abu-Bakar A.","year":"2005","unstructured":"Abu-Bakar A.; Moore M.R.; Lang M.A.; Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Biochem Pharmacol 2005,70(10),1527-1535","journal-title":"Biochem Pharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/pr.2012.23","volume":"71","author":"Gazzin S.","year":"2012","unstructured":"Gazzin S.; Zelenka J.; Zdrahalova L.; Konickova R.; Zabetta C.C.; Giraudi P.J.; Berengeno A.L.; Raseni A.; Robert M.C.; Vitek L.; Tiribelli C.; Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups. Pediatr Res 2012,71(6),653-660","journal-title":"Pediatr Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1038\/sj.jp.7210634","volume":"21","author":"Hansen T.W.R.","year":"2001","unstructured":"Hansen T.W.R.; Bilirubin brain toxicity. J Perinatol 2001,21(S1)(Suppl. 1),S48-S51","journal-title":"J Perinatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2004.07.063","volume":"1026","author":"Brito M.A.","year":"2004","unstructured":"Brito M.A.; Brites D.; Butterfield D.A.; A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res 2004,1026(1),33-43","journal-title":"Brain Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00005072-198401000-00004","volume":"43","author":"Ahdab-Barmada M.","year":"1984","unstructured":"Ahdab-Barmada M.; Moossy J.; The neuropathology of kernicterus in the premature neonate: Diagnostic problems. J Neuropathol Exp Neurol 1984,43(1),45-56","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12035-012-8364-8","volume":"47","author":"Barateiro A.","year":"2013","unstructured":"Barateiro A.; Miron V.E.; Santos S.D.; Relvas J.B.; Fernandes A.; Ffrench-Constant C.; Brites D.; Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination. Mol Neurobiol 2013,47(2),632-644","journal-title":"Mol Neurobiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/dneu.20727","volume":"69","author":"Fernandes A.","year":"2009","unstructured":"Fernandes A.; Falc\u00e3o A.S.; Abranches E.; Bekman E.; Henrique D.; Lanier L.M.; Brites D.; Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis. Dev Neurobiol 2009,69(9),568-582","journal-title":"Dev Neurobiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0022-2275(20)30269-8","volume":"42","author":"Zucker S.D.","year":"2001","unstructured":"Zucker S.D.; Goessling W.; Bootle E.J.; Sterritt C.; Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching. J Lipid Res 2001,42(9),1377-1388","journal-title":"J Lipid Res"},{"key":"ref=63","first-page":"82","volume":"24","author":"Schutta H.S.","year":"1971","unstructured":"Schutta H.S.; Johnson L.; Electron microscopic observations on acute bilirubin encephalopathy in Gunn rats induced by sulfadimethoxine. Lab Invest 1971,24(1),82-89","journal-title":"Lab Invest"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1203\/00006450-199111000-00015","volume":"30","author":"Wennberg R.P.","year":"1991","unstructured":"Wennberg R.P.; Johansson B.B.; Folbergrov\u00e1 J.; Siesj\u00f6 B.K.; Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier. Pediatr Res 1991,30(5),473-478","journal-title":"Pediatr Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1471-4159.1968.tb05909.x","volume":"15","author":"Vogt M.T.","year":"1968","unstructured":"Vogt M.T.; Basford R.E.; The effect of bilirubin on the energy metabolism of brain mitochondria. J Neurochem 1968,15(11),1313-1320","journal-title":"J Neurochem"},{"key":"ref=66","first-page":"e18","volume":"119","author":"Soto Conti C.P.","year":"2021","unstructured":"Soto Conti C.P.; Bilirubin: The toxic mechanisms of an antioxidant molecule. Arch Argent Pediatr 2021,119(1),e18-e25","journal-title":"Arch Argent Pediatr"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clp.2016.01.007","volume":"43","author":"Watchko J.F.","year":"2016","unstructured":"Watchko J.F.; Bilirubin-induced neurotoxicity in the preterm neonate. 2016,43(2),297-311"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e1739","DOI":"10.1038\/cddis.2015.113","volume":"6","author":"Bortolussi G","year":"2015","unstructured":"Bortolussi G; Codarin E; Antoniali G; Vascotto C; Vodret S; Arena S.; Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice. 2015,6(50),e1739"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1801243","DOI":"10.1155\/2018\/1801243","volume":"2018","author":"Rawat V.","year":"2018","unstructured":"Rawat V.; Bortolussi G.; Gazzin S.; Tiribelli C.; Muro A.F.; Bilirubin-induced oxidative stress leads to DNA damage in the cerebellum of hyperbilirubinemic neonatal mice and activates DNA double-strand break repair pathways in human cells. Oxid Med Cell Longev 2018,2018,1801243","journal-title":"Oxid Med Cell Longev"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/jp.2014.45","volume":"34","author":"Basu S.","year":"2014","unstructured":"Basu S.; De D.; Dev Khanna H.; Kumar A.; Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia. J Perinatol 2014,34(7),519-523","journal-title":"J Perinatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/exnr.2000.7518","volume":"166","author":"Grojean S.","year":"2000","unstructured":"Grojean S.; Koziel V.; Vert P.; Daval J.L.; Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 2000,166(2),334-341","journal-title":"Exp Neurol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","volume":"451","author":"Novelli A.","year":"1988","unstructured":"Novelli A.; Reilly J.A.; Lysko P.G.; Henneberry R.C.; Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988,451(1-2),205-212","journal-title":"Brain Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0079-6123(04)48029-7","volume":"148","author":"Slemmer J.E.","year":"2005","unstructured":"Slemmer J.E.; De Zeeuw C.I.; Weber J.T.; Don\u2019t get too excited: Mechanisms of glutamate-mediated Purkinje cell death. Prog Brain Res 2005,148,367-390","journal-title":"Prog Brain Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/088307380001500904","volume":"15","author":"Johnston M.V.","year":"2000","unstructured":"Johnston M.V.; Hoon A.H.; Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 2000,15(9),588-591","journal-title":"J Child Neurol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1523\/JNEUROSCI.07-04-01022.1987","volume":"7","author":"Greenamyre T.","year":"1987","unstructured":"Greenamyre T.; Penney J.B.; Young A.B.; Hudson C.; Silverstein F.S.; Johnston M.V.; Evidence for transient perinatal glutamatergic innervation of globus pallidus. J Neurosci 1987,7(4),1022-1030","journal-title":"J Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0378-5955(02)00494-X","volume":"171","author":"Spencer R.F.","year":"2002","unstructured":"Spencer R.F.; Shaia W.T.; Gleason A.T.; Sismanis A.; Shapiro S.M.; Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat. Hear Res 2002,171(1-2),129-141","journal-title":"Hear Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1203\/00006450-199512000-00020","volume":"38","author":"Churn S.B.","year":"1995","unstructured":"Churn S.B.; DeLorenzo R.J.; Shapiro S.M.; Bilirubin induces a calcium-dependent inhibition of multifunctional Ca2+\/calmodulin-dependent kinase II activity in vitro. Pediatr Res 1995,38(6),949-954","journal-title":"Pediatr Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0378-5955(02)00631-7","volume":"173","author":"Shaia W.T.","year":"2002","unstructured":"Shaia W.T.; Shapiro S.M.; Heller A.J.; Galiani D.L.; Sismanis A.; Spencer R.F.; Immunohistochemical localization of calcium-binding proteins in the brainstem vestibular nuclei of the jaundiced Gunn rat. Hear Res 2002,173(1-2),82-90","journal-title":"Hear Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/exnr.1997.6762","volume":"150","author":"McDonald J.W.","year":"1998","unstructured":"McDonald J.W.; Shapiro S.M.; Silverstein F.S.; Johnston M.V.; Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol 1998,150(1),21-29","journal-title":"Exp Neurol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1053\/jhep.2002.32967","volume":"35","author":"Rodrigues C.M.P.","year":"2002","unstructured":"Rodrigues C.M.P.; Sol\u00e1 S.; Brites D.; Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 2002,35(5),1186-1195","journal-title":"Hepatology"},{"key":"ref=81","first-page":"156","volume":"43","author":"Tiribelli C.","year":"2004","unstructured":"Tiribelli C.; Ostrow J.D.; The molecular basis of bilirubin encephalopathy and toxicity: 2004,43(1),156-166"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neulet.2003.09.053","volume":"353","author":"Lin S.","year":"2003","unstructured":"Lin S.; Yan C.; Wei X.; Paul S.M.; Du Y.; p38 MAP kinase mediates bilirubin-induced neuronal death of cultured rat cerebellar granule neurons. Neurosci Lett 2003,353(3),209-212","journal-title":"Neurosci Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00204-016-1835-3","volume":"91","author":"Qaisiya M.","year":"2017","unstructured":"Qaisiya M.; Brischetto C.; Ja\u0161prov\u00e1 J.; Vitek L.; Tiribelli C.; Bellarosa C.; Bilirubin-induced ER stress contributes to the inflammatory response and apoptosis in neuronal cells. Arch Toxicol 2017,91(4),1847-1858","journal-title":"Arch Toxicol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1203\/01.pdr.0000191135.63586.08","volume":"59","author":"Hank\u00f8 E.","year":"2006","unstructured":"Hank\u00f8 E.; Hansen T.W.; Almaas R.; Paulsen R.; Rootwelt T.; Synergistic protection of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in human NT2-N neurons. Pediatr Res 2006,59(1),72-77","journal-title":"Pediatr Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1203\/00006450-200204000-00022","volume":"51","author":"Silva R.F.M.","year":"2002","unstructured":"Silva R.F.M.; Rodrigues C.M.P.; Brites D.; Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin. Pediatr Res 2002,51(4),535-541","journal-title":"Pediatr Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0168-8278(01)00015-0","volume":"34","author":"Silva R.F.M.","year":"2001","unstructured":"Silva R.F.M.; Rodrigues C.M.P.; Brites D.; Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 2001,34(3),402-408","journal-title":"J Hepatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1203\/01.PDR.0000148711.11519.A5","volume":"57","author":"Hank\u00f8 E.","year":"2005","unstructured":"Hank\u00f8 E.; Hansen T.W.; Almaas R.; Lindstad J.; Rootwelt T.; Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res 2005,57(2),179-184","journal-title":"Pediatr Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fphar.2012.00088","volume":"3","author":"Brites D.","year":"2012","unstructured":"Brites D.; The evolving landscape of neurotoxicity by unconjugated bilirubin: Role of glial cells and inflammation. Front Pharmacol 2012,3,88","journal-title":"Front Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1074\/jbc.M113.518613","volume":"289","author":"Yueh M.F.","year":"2014","unstructured":"Yueh M.F.; Chen S.; Nguyen N.; Tukey R.H.; Developmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice. J Biol Chem 2014,289(8),4699-4709","journal-title":"J Biol Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41100-020-00265-0","volume":"6","author":"El Chediak A.","year":"2020","unstructured":"El Chediak A.; Janom K.; Koubar S.H.; Bile cast nephropathy: When the kidneys turn yellow. Renal Replacement Ther 2020,6(1),1-7","journal-title":"Renal Replacement Ther"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/ki.1990.296","volume":"38","author":"Sitprija V.","year":"1990","unstructured":"Sitprija V.; Kashemsant U.; Sriratanaban A.; Arthachinta S.; Poshyachinda V.; Renal function in obstructive jaundice in man: Cholangiocarcinoma model. Kidney Int 1990,38(5),948-955","journal-title":"Kidney Int"},{"key":"ref=92","first-page":"229","volume":"19","author":"Betjes M.G.H.","year":"2006","unstructured":"Betjes M.G.H.; Bajema I.; The pathology of jaundice-related renal insufficiency: Cholemic nephrosis revisited. J Nephrol 2006,19(2),229-233","journal-title":"J Nephrol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15586\/jrenhep.2019.52","volume":"3","author":"Chvez-Iiguez J.S.","year":"2019","unstructured":"Chvez-Iiguez J.S.; Meza-Ros A.; Santos-Garcia A.; Garca-Garca G.; Armendriz-Borunda J.; Cholemic nephropathy: Hyperbilirubinemia and its impact on renal function. J. Renal Hepatic Disorders 2019,3(1),33-39","journal-title":"Renal Hepatic Disorders"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1053\/jhep.2001.25089","volume":"33","author":"Bairaktari E.","year":"2001","unstructured":"Bairaktari E.; Liamis G.; Tsolas O.; Elisaf M.; Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology 2001,33(6),1365-1369","journal-title":"Hepatology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.redox.2015.12.009","volume":"8","author":"Mart\u00ednez-Cecilia D.","year":"2016","unstructured":"Mart\u00ednez-Cecilia D.; Reyes-D\u00edaz M.; Ruiz-Rabelo J.; Gomez-Alvarez M.; Villanueva C.M.; \u00c1lamo J.; Muntan\u00e9 J.; Padillo F.J.; Oxidative stress influence on renal dysfunction in patients with obstructive jaundice: A case and control prospective study. Redox Biol 2016,8,160-164","journal-title":"Redox Biol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"bcr-2015-213257","DOI":"10.1136\/bcr-2015-213257","volume":"2016","author":"Sens F.","year":"2016","unstructured":"Sens F.; Bacchetta J.; Rabeyrin M.; Juillard L.; Efficacy of extracorporeal albumin dialysis for acute kidney injury due to cholestatic jaundice nephrotoxicity. BMJ Case Rep 2016,2016,bcr-2015-213257","journal-title":"BMJ Case Rep"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/hep.26599","volume":"58","author":"Fickert P.","year":"2013","unstructured":"Fickert P.; Krones E.; Pollheimer M.J.; Thueringer A.; Moustafa T.; Silbert D.; Halilbasic E.; Yang M.; Jaeschke H.; Stokman G.; Wells R.G.; Eller K.; Rosenkranz A.R.; Eggertsen G.; Wagner C.A.; Langner C.; Denk H.; Trauner M.; Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013,58(6),2056-2069","journal-title":"Hepatology"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2017.02.019","volume":"67","author":"Krones E.","year":"2017","unstructured":"Krones E.; Eller K.; Pollheimer M.J.; Racedo S.; Kirsch A.H.; Frauscher B.; Wahlstr\u00f6m A.; St\u00e5hlman M.; Trauner M.; Grahammer F.; Huber T.B.; Wagner K.; Rosenkranz A.R.; Marschall H.U.; Fickert P.; NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice. J Hepatol 2017,67(1),110-119","journal-title":"J Hepatol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2006.06.012","volume":"374","author":"Alexandra Brito M.","year":"2006","unstructured":"Alexandra Brito M.; Silva R.F.; Brites D.; Bilirubin toxicity to human erythrocytes: A review. Clin Chim Acta 2006,374(1-2),46-56","journal-title":"Clin Chim Acta"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.cdd.4400404","volume":"5","author":"Fadok V.A.","year":"1998","unstructured":"Fadok V.A.; Bratton D.L.; Frasch S.C.; Warner M.L.; Henson P.M.; The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. 1998,5,551"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1365-2362.2000.00612.x","volume":"30","author":"Brito M.A.","year":"2000","unstructured":"Brito M.A.; Silva R.; Tiribelli C.; Brites D.; Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management. Eur J Clin Invest 2000,30(3),239-247","journal-title":"Eur J Clin Invest"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0009-8981(96)06285-7","volume":"249","author":"Brito M.A.","year":"1996","unstructured":"Brito M.A.; Silva R.M.; Matos D.C.; da Silva A.T.; Brites D.T.; Alterations of erythrocyte morphology and lipid composition by hyperbilirubinemia. Clin Chim Acta 1996,249(1-2),149-165","journal-title":"Clin Chim Acta"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0165-022X(98)00049-9","volume":"39","author":"Tayyab S.","year":"1999","unstructured":"Tayyab S.; Ali M.K.; A comparative study on the extraction of membrane-bound bilirubin from erythrocyte membranes using various methods. J Biochem Biophys Methods 1999,39(1-2),39-45","journal-title":"J Biochem Biophys Methods"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"Jones P.A.","year":"2002","unstructured":"Jones P.A.; Baylin S.B.; The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002,3(6),415-428","journal-title":"Nat Rev Genet"},{"key":"ref=105","first-page":"17","volume":"61","author":"Strom P.","year":"2007","unstructured":"Strom P.; Snve O.; Rossi J.J.; Epigenetics and microRNAs. Nature 2007,61,17-23","journal-title":"Nature"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12263-018-0623-5","volume":"13","author":"Moradi Sarabi M.","year":"2018","unstructured":"Moradi Sarabi M.; Zahedi S.A.; Pajouhi N.; Khosravi P.; Bagheri S.; Ahmadvand H.; Shahryarhesami S.; The effects of dietary polyunsaturated fatty acids on miR-126 promoter DNA methylation status and VEGF protein expression in the colorectal cancer cells. Genes Nutr 2018,13(1),32","journal-title":"Genes Nutr"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.7314\/APJCP.2015.16.18.8247","volume":"16","author":"Mokarram P.","year":"2015","unstructured":"Mokarram P.; Shakiba-Jam F.; Kavousipour S.; Sarabi M.M.; Seghatoleslam A.; Promoter methylation status of two novel human genes, UBE2Q1 and UBE2Q2, in colorectal cancer: A new finding in Iranian patients. Asian Pac J Cancer Prev 2015,16(18),8247-8252","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1677\/joe.1.06546","volume":"191","author":"Maruyama T.","year":"2006","unstructured":"Maruyama T.; Tanaka K.; Suzuki J.; Miyoshi H.; Harada N.; Nakamura T.; Miyamoto Y.; Kanatani A.; Tamai Y.; Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1\/M-Bar) in mice. J Endocrinol 2006,191(1),197-205","journal-title":"J Endocrinol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","volume":"10","author":"Thomas C.","year":"2009","unstructured":"Thomas C.; Gioiello A.; Noriega L.; Strehle A.; Oury J.; Rizzo G.; Macchiarulo A.; Yamamoto H.; Mataki C.; Pruzanski M.; Pellicciari R.; Auwerx J.; Schoonjans K.; TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009,10(3),167-177","journal-title":"Cell Metab"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"Wang Y.D.","year":"2011","unstructured":"Wang Y.D.; Chen W.D.; Yu D.; Forman B.M.; Huang W.; The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor \u03ba light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology 2011,54(4),1421-1432","journal-title":"Hepatology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1210\/me.2009-0045","volume":"23","author":"Ahlbory-Dieker D.L.","year":"2009","unstructured":"Ahlbory-Dieker D.L.; Stride B.D.; Leder G.; Schkoldow J.; Tr\u00f6lenberg S.; Seidel H.; Otto C.; Sommer A.; Parker M.G.; Sch\u00fctz G.; Wintermantel T.M.; DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Mol Endocrinol 2009,23(10),1544-1555","journal-title":"Mol Endocrinol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.1840080623","volume":"8","author":"Villa E.","year":"1988","unstructured":"Villa E.; Baldini G.M.; Rossini G.P.; Pasquinelli C.; Melegari M.; Cariani E.; Tata C.; Bellentani S.; Ferrari A.; Manenti F.; Ethanol-induced increase in cytosolic estrogen receptors in human male liver: A possible explanation for biochemical feminization in chronic liver disease due to alcohol. Hepatology 1988,8(6),1610-1614","journal-title":"Hepatology"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"818","DOI":"10.17235\/reed.2017.4426\/2016","volume":"109","author":"Fan X.P.","year":"2017","unstructured":"Fan X.P.; Dou C.Y.; Fan Y.C.; Cao C.J.; Zhao Z.H.; Wang K.; Methylation status of the estrogen receptor 1 promoter predicts poor prognosis of acute-on-chronic hepatitis B liver failure. Rev Esp Enferm Dig 2017,109(12),818-827","journal-title":"Rev Esp Enferm Dig"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1074\/jbc.M306439200","volume":"279","author":"Basu N.K.","year":"2004","unstructured":"Basu N.K.; Ciotti M.; Hwang M.S.; Kole L.; Mitra P.S.; Cho J.W.; Owens I.S.; Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. J Biol Chem 2004,279(2),1429-1441","journal-title":"J Biol Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1124\/mol.65.4.953","volume":"65","author":"Gregory P.A.","year":"2004","unstructured":"Gregory P.A.; Lewinsky R.H.; Gardner-Stephen D.A.; Mackenzie P.I.; Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2. Mol Pharmacol 2004,65(4),953-963","journal-title":"Mol Pharmacol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bcp.2013.11.001","volume":"87","author":"Oda S.","year":"2014","unstructured":"Oda S.; Fukami T.; Yokoi T.; Nakajima M.; Epigenetic regulation of the tissue-specific expression of human UDP-glucuronosyltransferase (UGT) 1A10. Biochem Pharmacol 2014,87(4),660-667","journal-title":"Biochem Pharmacol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/1756283X17731520","volume":"10","author":"Kathawala M.","year":"2017","unstructured":"Kathawala M.; Hirschfield G.M.; Insights into the management of Wilson\u2019s disease. Therap Adv Gastroenterol 2017,10(11),889-905","journal-title":"Therap Adv Gastroenterol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/gps.1469","volume":"21","author":"Kim T.S.","year":"2006","unstructured":"Kim T.S.; Pae C.U.; Yoon S.J.; Jang W.Y.; Lee N.J.; Kim J.J.; Lee S.J.; Lee C.; Paik I.H.; Lee C.U.; Decreased plasma antioxidants in patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry 2006,21(4),344-348","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ncb2748","volume":"15","author":"Wang T.","year":"2013","unstructured":"Wang T.; Wu H.; Li Y.; Szulwach K.E.; Lin L.; Li X.; Chen I.P.; Goldlust I.S.; Chamberlain S.J.; Dodd A.; Gong H.; Ananiev G.; Han J.W.; Yoon Y.S.; Rudd M.K.; Yu M.; Song C.X.; He C.; Chang Q.; Warren S.T.; Jin P.; Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol 2013,15(6),700-711","journal-title":"Nat Cell Biol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1111\/bph.12590","volume":"171","author":"Park K.C.","year":"2014","unstructured":"Park K.C.; Park J.H.; Jeon J.Y.; Kim S.Y.; Kim J.M.; Lim C.Y.; Lee T.H.; Kim H.K.; Lee H.G.; Kim S.M.; Kwon H.J.; Suh J.S.; Kim S.W.; Choi S.H.; A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells. Br J Pharmacol 2014,171(21),4820-4830","journal-title":"Br J Pharmacol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2006.09.017","volume":"46","author":"Murata K.","year":"2007","unstructured":"Murata K.; Hamada M.; Sugimoto K.; Nakano T.; A novel mechanism for drug-induced liver failure: Inhibition of histone acetylation by hydralazine derivatives. J Hepatol 2007,46(2),322-329","journal-title":"J Hepatol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00535-013-0892-0","volume":"49","author":"Sheen-Chen S.M.","year":"2014","unstructured":"Sheen-Chen S.M.; Lin C.R.; Chen K.H.; Yang C.H.; Lee C.T.; Huang H.W.; Huang C.Y.; Epigenetic histone methylation regulates transforming growth factor \u03b2-1 expression following bile duct ligation in rats. J Gastroenterol 2014,49(8),1285-1297","journal-title":"J Gastroenterol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"Rao R.C.","year":"2015","unstructured":"Rao R.C.; Dou Y.; Hijacked in cancer: The KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 2015,15(6),334-346","journal-title":"Nat Rev Cancer"},{"key":"ref=124","first-page":"5167","volume":"9","author":"Liang W.","year":"2016","unstructured":"Liang W.; Lscher-Firzlaff J.; Ullius A.; Schneider U.; Longerich T.; Lscher B.; Loss of the epigenetic regulator Ash2l results in desintegration of hepatocytes and liver failure. Int J Clin Exp Pathol 2016,9,5167","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajg.2019.01.011","volume":"20","author":"El Samaloty N.M.","year":"2019","unstructured":"El Samaloty N.M.; Hassan Z.A.; Hefny Z.M.; Abdelaziz D.H.A.; Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients. Arab J Gastroenterol 2019,20(1),1-7","journal-title":"Arab J Gastroenterol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Qu Y.","year":"2017","unstructured":"Qu Y.; Zhang Q.; Cai X.; Li F.; Ma Z.; Xu M.; Lu L.; Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med 2017,21(10),2491-2502","journal-title":"J Cell Mol Med"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2014.04.024","volume":"107","author":"Chen S.","year":"2014","unstructured":"Chen S.; He N.; Yu J.; Li L.; Hu Y.; Deng R.; Zhong S.; Shen L.; Post-transcriptional regulation by miR-137 underlies the low abundance of CAR and low rate of bilirubin clearance in neonatal mice. Life Sci 2014,107(1-2),8-13","journal-title":"Life Sci"},{"key":"ref=128","first-page":"10687","volume":"24","author":"Liu H.H.","year":"2020","unstructured":"Liu H.H.; Li A.J.; MiR-340 suppresses CCl4-induced acute liver injury through exerting anti-inflammation targeting Sigirr. Eur Rev Med Pharmacol Sci 2020,24(20),10687-10695","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.ymthe.2018.08.022","volume":"26","author":"Kumar V.","year":"2018","unstructured":"Kumar V.; Kumar V.; Luo J.; Mahato R.I.; Therapeutic potential of OMe-PS-miR-29b1 for treating liver fibrosis. Mol Ther 2018,26(12),2798-2811","journal-title":"Mol Ther"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"E189","DOI":"10.1111\/hepr.12198","volume":"44","author":"Katsushima F.","year":"2014","unstructured":"Katsushima F.; Takahashi A.; Sakamoto N.; Kanno Y.; Abe K.; Ohira H.; Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res 2014,44(10),E189-E197","journal-title":"Hepatol Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/jvh.12138","volume":"21","author":"Song G.","year":"2014","unstructured":"Song G.; Jia H.; Xu H.; Liu W.; Zhu H.; Li S.; Shi J.; Li Z.; He J.; Chen Z.; Studying the association of microRNA-210 level with chronic hepatitis B progression. J Viral Hepat 2014,21(4),272-280","journal-title":"J Viral Hepat"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"e26971","DOI":"10.1371\/journal.pone.0026971","volume":"6","author":"Bihrer V.","year":"2011","unstructured":"Bihrer V.; Waidmann O.; Friedrich-Rust M.; Forestier N.; Susser S.; Haupenthal J.; Welker M.; Shi Y.; Peveling-Oberhag J.; Polta A.; von Wagner M.; Radeke H.H.; Sarrazin C.; Trojan J.; Zeuzem S.; Kronenberger B.; Piiper A.; Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 2011,6(10),e26971","journal-title":"PLoS One"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"e13790","DOI":"10.1111\/ctr.13790","volume":"34","author":"Matton A.P.M.","year":"2020","unstructured":"Matton A.P.M.; Selten J.W.; Roest H.P.; de Jonge J.; IJzermans J.N.M.; de Meijer V.E.; Porte R.J.; van der Laan L.J.W.; Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers. Clin Transplant 2020,34(3),e13790","journal-title":"Clin Transplant"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fmed.2019.00030","volume":"6","author":"Eguchi A.","year":"2019","unstructured":"Eguchi A.; Franz N.; Kobayashi Y.; Iwasa M.; Wagner N.; Hildebrand F.; Takei Y.; Marzi I.; Relja B.; Circulating extracellular vesicles and their miR Barcode differentiate alcohol drinkers with liver injury and those without liver injury in severe trauma patients. Front Med (Lausanne) 2019,6(FEB),30","journal-title":"Front Med (Lausanne)"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ajg.2019.11.003","volume":"20","author":"Nasser M.Z.","year":"2019","unstructured":"Nasser M.Z.; Zayed N.A.; Mohamed A.M.; Attia D.; Esmat G.; Khairy A.; Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients. Arab J Gastroenterol 2019,20(4),198-204","journal-title":"Arab J Gastroenterol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0300060513499093","volume":"42","author":"Ruoquan Y.","year":"2014","unstructured":"Ruoquan Y.; Wanpin N.; Qiangsheng X.; Guodong T.; Feizhou H.; Correlation between plasma miR-122 expression and liver injury induced by hepatectomy. J Int Med Res 2014,42(1),77-84","journal-title":"J Int Med Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biologicals.2019.02.002","volume":"58","author":"Fathi-Kazerooni M.","year":"2019","unstructured":"Fathi-Kazerooni M.; Kazemnejad S.; Khanjani S.; Saltanatpour Z.; Tavoosidana G.; Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals 2019,58,64-72","journal-title":"Biologicals"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1042\/CS20160216","volume":"130","author":"Roy S.","year":"2016","unstructured":"Roy S.; Benz F.; Alder J.; Bantel H.; Janssen J.; Vucur M.; Gautheron J.; Schneider A.; Sch\u00fcller F.; Loosen S.; Luedde M.; Koch A.; Tacke F.; Luedde T.; Trautwein C.; Roderburg C.; Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury. Clin Sci (Lond) 2016,130(14),1197-1207","journal-title":"Clin Sci (Lond)"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/liv.12627","volume":"35","author":"Roderburg C.","year":"2015","unstructured":"Roderburg C.; Benz F.; Vargas Cardenas D.; Koch A.; Janssen J.; Vucur M.; Gautheron J.; Schneider A.T.; Koppe C.; Kreggenwinkel K.; Zimmermann H.W.; Luedde M.; Trautwein C.; Tacke F.; Luedde T.; Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int 2015,35(4),1172-1184","journal-title":"Liver Int"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12871-018-0541-5","volume":"18","author":"Rahmel T.","year":"2018","unstructured":"Rahmel T.; Rump K.; Adamzik M.; Peters J.; Frey U.H.; Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome. BMC Anesthesiol 2018,18(1),75","journal-title":"BMC Anesthesiol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10096-019-03747-0","volume":"39","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Huang Y.; Wang Q.; Ma Y.; Qi Y.; Liu Z.; Deng J.; Ruan Q.; Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage. Eur J Clin Microbiol Infect Dis 2020,39(3),471-481","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jn\/nxaa001","volume":"150","author":"Calkins K.L.","year":"2020","unstructured":"Calkins K.L.; Thamotharan S.; Ghosh S.; Dai Y.; Devaskar S.U.; MicroRNA 122 reflects liver injury in children with intestinal failure-associated liver disease treated with intravenous fish oil. J Nutr 2020,150(5),1144-1150","journal-title":"J Nutr"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s12185-018-2429-z","volume":"107","author":"Xing L.","year":"2018","unstructured":"Xing L.; Xu W.; Qu Y.; Zhao M.; Zhu H.; Liu H.; Wang H.; Su X.; Shao Z.; miR-150 regulates B lymphocyte in autoimmune hemolytic anemia\/Evans syndrome by c-Myb. Int J Hematol 2018,107(6),666-672","journal-title":"Int J Hematol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.dld.2018.08.030","volume":"51","author":"Tao Y.C.","year":"2019","unstructured":"Tao Y.C.; Wang M.L.; Wang M.; Ma Y.J.; Bai L.; Feng P.; Chen E.Q.; Tang H.; Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure. Dig Liver Dis 2019,51(3),412-418","journal-title":"Dig Liver Dis"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"4850472","DOI":"10.1155\/2019\/4850472","volume":"2019","author":"Roderburg C.","year":"2019","unstructured":"Roderburg C.; Koch A.; Benz F.; Vucur M.; Spehlmann M.; Loosen S.H.; Luedde M.; Rehse S.; Lurje G.; Trautwein C.; Tacke F.; Luedde T.; Serum levels of miR-143 predict survival in critically Ill patients. Dis Markers 2019,2019,4850472","journal-title":"Dis Markers"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/jvh.12696","volume":"24","author":"Shaker O.G.","year":"2017","unstructured":"Shaker O.G.; Senousy M.A.; Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients. J Viral Hepat 2017,24(8),636-644","journal-title":"J Viral Hepat"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/2211536607666180821162850","volume":"8","author":"Jiang S.","year":"2019","unstructured":"Jiang S.; Jiang W.; Xu Y.; Wang X.; Mu Y.; Liu P.; Serum miR-21 and miR-26a levels negatively correlate with severity of cirrhosis in patients with chronic hepatitis B. MicroRNA 2019,8(1),86-92","journal-title":"MicroRNA"},{"key":"ref=148","first-page":"2605","volume":"11","author":"Chen C.","year":"2018","unstructured":"Chen C.; Zhang L.; Huang H.; Liu S.; Liang Y.; Xu L.; Li S.; Cheng Y.; Tang W.; Serum miR-126-3p level is down-regulated in sepsis patients. Int J Clin Exp Pathol 2018,11(5),2605-2612","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=149","first-page":"533","volume":"21","author":"Qian C.","year":"2013","unstructured":"Qian C.; Chen S.X.; Ren C.L.; Zhong R.Q.; Deng A.M.; Qin Q.; [Abnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significance]. Chung Hua Kan Tsang Ping Tsa Chih 2013,21(7),533-536","journal-title":"Chung Hua Kan Tsang Ping Tsa Chih"},{"key":"ref=150","first-page":"247","volume":"8","author":"Ayoub S.E.","year":"2019","unstructured":"Ayoub S.E.; Shaker O.G.; Abdelwahed M.Y.; Ahmed N.A.; Abdelhameed H.G.; Bosilah A.H.; Mohammed S.R.; Association of MicroRNA-155rs767649 polymorphism with susceptibility to preeclampsia. Int J Mol Cell Med 2019,8(4),247-257","journal-title":"Int J Mol Cell Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/14737159.2018.1415145","volume":"18","author":"Howell L.S.","year":"2018","unstructured":"Howell L.S.; Ireland L.; Park B.K.; Goldring C.E.; MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury. Expert Rev Mol Diagn 2018,18(1),47-54","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ehf2.12123","volume":"4","author":"Koyama S.","year":"2017","unstructured":"Koyama S.; Kuragaichi T.; Sato Y.; Kuwabara Y.; Usami S.; Horie T.; Baba O.; Hakuno D.; Nakashima Y.; Nishino T.; Nishiga M.; Nakao T.; Arai H.; Kimura T.; Ono K.; Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation. ESC Heart Fail 2017,4(2),112-121","journal-title":"ESC Heart Fail"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"155076","DOI":"10.1016\/j.cyto.2020.155076","volume":"131","author":"Ma Z.H.","year":"2020","unstructured":"Ma Z.H.; Sun C.X.; Shi H.; Fan J.H.; Song Y.G.; Cong P.J.; Kong X.M.; Hao D.L.; Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections. Cytokine 2020,131,155076","journal-title":"Cytokine"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jmv.24829","volume":"89","author":"Jiao X.","year":"2017","unstructured":"Jiao X.; Fan Z.; Chen H.; He P.; Li Y.; Zhang Q.; Ke C.; Serum and exosomal miR-122 and miR-199a as a biomarker to predict therapeutic efficacy of hepatitis C patients. J Med Virol 2017,89(9),1597-1605","journal-title":"J Med Virol"},{"key":"ref=155","first-page":"25","volume":"4","author":"Elmouttaleb A.T.A.","year":"2015","unstructured":"Elmouttaleb A.T.A.; Abd-elatif D.M.; Soliman G.M.; Serum Micro RNA-122 as a biomarker for hepatocellular carcinoma in chronic hepatitis C virus patients. Res Cancer Tumor 2015,4,25-33","journal-title":"Res Cancer Tumor"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"e45652","DOI":"10.1371\/journal.pone.0045652","volume":"7","author":"Waidmann O.","year":"2012","unstructured":"Waidmann O.; K\u00f6berle V.; Brunner F.; Zeuzem S.; Piiper A.; Kronenberger B.; Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One 2012,7(9),e45652","journal-title":"PLoS One"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"e66577","DOI":"10.1371\/journal.pone.0066577","volume":"8","author":"Chen Y.J.","year":"2013","unstructured":"Chen Y.J.; Zhu J.M.; Wu H.; Fan J.; Zhou J.; Hu J.; Yu Q.; Liu T.T.; Yang L.; Wu C.L.; Guo X.L.; Huang X.W.; Shen X.Z.; Circulating microRNAs as a fingerprint for liver cirrhosis. PLoS One 2013,8(6),e66577","journal-title":"PLoS One"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/ajg.2011.161","volume":"106","author":"Bihrer V.","year":"2011","unstructured":"Bihrer V.; Friedrich-Rust M.; Kronenberger B.; Forestier N.; Haupenthal J.; Shi Y.; Peveling-Oberhag J.; Radeke H.H.; Sarrazin C.; Herrmann E.; Zeuzem S.; Waidmann O.; Piiper A.; Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011,106(9),1663-1669","journal-title":"Am J Gastroenterol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.24538","volume":"54","author":"Starkey Lewis P.J.","year":"2011","unstructured":"Starkey Lewis P.J.; Dear J.; Platt V.; Simpson K.J.; Craig D.G.N.; Antoine D.J.; French N.S.; Dhaun N.; Webb D.J.; Costello E.M.; Neoptolemos J.P.; Moggs J.; Goldring C.E.; Park B.K.; Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011,54(5),1767-1776","journal-title":"Hepatology"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666211125102924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/198306\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666211125102924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:13:15Z","timestamp":1693224795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/198306\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":159,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530321666211125102924","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}